ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ELOX Eloxx Pharmaceuticals Inc

3.82
0.00 (0.00%)
Apr 11 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Eloxx Pharmaceuticals Inc ELOX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 3.82 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.82 3.82
more quote information »

Recent News

Date Time Source Heading
4/01/202416:02EDGAR2Form NT 10-K - Notification of inability to timely file Form..
3/29/202416:11EDGAR2Form 8-K - Current report
3/21/202414:20EDGAR2Form 25-NSE - Notification filed by national security..
3/14/202416:30EDGAR2Form 8-K - Current report
3/13/202411:42GLOBEAlmirall and Eloxx Pharmaceuticals Enter into Exclusive..
1/26/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202421:44EDGAR2Form S-3 - Registration statement under Securities Act of..
1/24/202417:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/09/202417:10EDGAR2Form 8-K - Current report
12/28/202316:11EDGAR2Form 8-K - Current report
11/13/202316:15GLOBEEloxx Pharmaceuticals Reports Third Quarter 2023 Financial..
10/16/202317:26EDGAR2Form 8-K - Current report
10/09/202308:00GLOBEEloxx Pharmaceuticals Reports Additional Confirmation that..
9/20/202316:05EDGAR2Form 8-K - Current report
9/20/202313:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
9/19/202308:00GLOBEEloxx Pharmaceuticals Announces $2 Million Registered Direct..
9/18/202308:05EDGAR2Form 8-K - Current report
9/18/202307:00GLOBEEloxx Pharmaceuticals Reports Independent Confirmation of..
9/15/202317:15EDGAR2Form 8-K - Current report
9/07/202310:14EDGAR2Form 8-K - Current report
9/07/202309:00GLOBEEloxx Pharmaceuticals Provides Program Updates on ELX-02 and..
8/29/202316:32EDGAR2Form 8-K - Current report
8/21/202316:50EDGAR2Form 8-K - Current report
8/14/202311:56EDGAR2Form 8-K - Current report
8/14/202308:30GLOBEEloxx Pharmaceuticals Reports Second Quarter 2023 Financial..
8/14/202308:00GLOBEEloxx Pharmaceuticals Reports Drug Response in All Patients..
8/11/202316:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/11/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202316:01EDGAR2Form 8-K - Current report
8/03/202309:26GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
7/13/202308:43EDGAR2Form 8-K - Current report
7/10/202309:00GLOBEEloxx Pharmaceuticals Announces Publication Demonstrating..
6/28/202309:00GLOBEEloxx Pharmaceuticals Key Opinion Leader Event Highlights..
6/21/202313:30GLOBEEloxx Pharmaceuticals to Host Investor and Analyst Call on..
6/21/202309:00GLOBEEloxx Pharmaceuticals Highlights Recent Alport Syndrome..
6/14/202316:53GLOBEEloxx Pharmaceuticals Announces Final Data Assessment from..
6/06/202308:30GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
6/01/202309:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
5/24/202308:00GLOBEEloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal..
5/15/202316:30GLOBEEloxx Pharmaceuticals Reports First Quarter 2023 Financial..
5/02/202308:00GLOBEEloxx Pharmaceuticals Announces FDA Clearance to Begin..

Your Recent History

Delayed Upgrade Clock